perospirone has been researched along with haloperidol in 13 studies
| Studies (perospirone) | Trials (perospirone) | Recent Studies (post-2010) (perospirone) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
|---|---|---|---|---|---|
| 111 | 24 | 26 | 20,330 | 1,753 | 3,294 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrieux, M; Besançon, R; Giros, B; Martres, MP; Pilon, C; Schwartz, JC; Sokoloff, P | 1 |
| Ikeda, K; Ishibashi, T; Ishida, K; Kato, T; Nakamura, M; Ohno, Y | 1 |
| Hirose, A; Kato, T; Maruoka, Y; Nakamura, M; Ohno, Y; Tatsuno, T | 1 |
| Antoku, F; Ishizumi, K; Kojima, A; Saji, I; Yoshigi, M | 1 |
| Ishibashi, T; Ishida, K; Nakamura, M; Ohno, Y; Okada, K | 1 |
| Ikeda, K; Ishibashi, T; Ishida, K; Nakamura, M; Ohno, Y; Tojima, R; Yasui, J | 1 |
| Ishibashi, T; Ishida, K; Nakamura, M; Ohno, Y | 1 |
| Ishibashi, T; Ishida-Tokuda, K; Nakamura, M; Ohno, Y | 1 |
| Matsumoto, K; Nakamura, M; Ohno, Y; Sakamoto, H | 1 |
| Ito, C; Ojima, T; Sakurai, E; Watanabe, T; Yanai, K | 1 |
| Egashira, N; Fujiwara, M; Harada, S; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Okuno, R | 1 |
| Dierks, T; Irisawa, S; Isotani, T; Kikuchi, M; Kinoshita, T; Koenig, T; Okugawa, G; Strik, W; Yagyu, T; Yamada, K; Yoshimura, M | 1 |
| Fukui, N; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
1 trial(s) available for perospirone and haloperidol
| Article | Year |
|---|---|
A pharmaco-EEG study on antipsychotic drugs in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Cross-Over Studies; Dibenzothiazepines; Electroencephalography; Fourier Analysis; Haloperidol; Humans; Indoles; Isoindoles; Male; Olanzapine; Quetiapine Fumarate; Reference Values; Risperidone; Single-Blind Method; Thiazoles; Time Factors | 2007 |
12 other study(ies) available for perospirone and haloperidol
| Article | Year |
|---|---|
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.
Topics: Animals; Chlorides; CHO Cells; Cricetinae; Dopamine; Dopamine Agents; Dopamine Antagonists; Guanylyl Imidodiphosphate; Humans; Lithium; Lithium Chloride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Sodium Chloride; Sulpiride; Transfection | 1992 |
Effects of chronic treatments with SM-9018, a potential atypical neuroleptic, on behavioral dopaminergic and serotonergic sensitivities in rats.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Dopamine; Haloperidol; Indoles; Isoindoles; Male; Motor Activity; Posture; Rats; Rats, Sprague-Dawley; Serotonin; Stereotyped Behavior; Thiazoles | 1995 |
Effects of SM-9018, a potential atypical neuroleptic, on the central monoaminergic system in rats.
Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Haloperidol; In Vitro Techniques; Indoles; Isoindoles; Kinetics; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Thiazoles | 1993 |
Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Central Nervous System Depressants; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Indoles; Isoindoles; Mice; Motor Activity; Neostriatum; Psychotropic Drugs; Rats; Serotonin Antagonists; Spiro Compounds; Stereotyped Behavior; Structure-Activity Relationship; Succinimides; Thiazoles | 1995 |
Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats.
Topics: Animals; Antipsychotic Agents; Binding, Competitive; Haloperidol; Indoles; Isoindoles; Male; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Salicylamides; Serotonin Antagonists; Thiazoles; Up-Regulation | 1995 |
Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum.
Topics: Animals; Antipsychotic Agents; Corpus Striatum; Gene Expression; Genes, fos; Haloperidol; Indoles; Isoindoles; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists; Thiazoles | 1996 |
Effects of SM-9018, a novel 5-HT2 and D2 receptor antagonist, on electrically-evoked [3H]acetylcholine release from rat striatal slices.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electric Stimulation; Haloperidol; In Vitro Techniques; Indoles; Isoindoles; Male; Neostriatum; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin Antagonists; Thiazoles | 1996 |
Effects of perospirone (SM-9018), a potential atypical neuroleptic, on dopamine D1 receptor-mediated vacuous chewing movement in rats: a role of 5-HT2 receptor blocking activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Avoidance Learning; Dopamine Agonists; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Indoles; Isoindoles; Male; Mastication; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Thiazoles | 1997 |
Anxiolytic-like effects of perospirone, a novel serotonin-2 and dopamine-2 antagonist (SDA)-type antipsychotic agent.
Topics: Aggression; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Indoles; Interpersonal Relations; Isoindoles; Male; Rats; Serotonin Antagonists; Thiazoles | 1998 |
Effects of serotonin-dopamine antagonists on prepulse inhibition and neurotransmitter contents in the rat cortex.
Topics: Animals; Antipsychotic Agents; Cerebral Cortex; Cognition; Dopamine; Dopamine Antagonists; Haloperidol; Indoles; Isoindoles; Male; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Risperidone; Serotonin; Serotonin Antagonists; Thiazoles | 2004 |
Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Indoles; Isoindoles; Male; Mice; Mice, Inbred ICR; Motor Activity; Obsessive-Compulsive Disorder; Piperazines; Receptor, Serotonin, 5-HT1A; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 2005 |
Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
Topics: Antipsychotic Agents; Dibenzothiepins; Electrocardiography; Female; Haloperidol; Heart Rate; Humans; Isoindoles; Long QT Syndrome; Middle Aged; Schizophrenia; Thiazoles; Water-Electrolyte Imbalance | 2012 |